What we do
c-LEcta

c-LEcta is a leading industrial biotech company specializing in the discovery, optimization and production of best-in-class enzymes, and in strain engineering for the production of small molecules and proteins. 




What We Do

c-LEcta GmbH was established in September 2004 as a spin-off from the University of Leipzig. To date, c-LEcta has shaped into a leading industrial biotech company and provides customized, best-in-class enzymes and microbial strains for the production of high value industrial products. c-LEcta constantly improves its own proprietary technologies and processes and supports industrial partners in both new and existing markets. The knowledge and expertise of over 50 employees in the discovery, optimization and production of enzymes, as well as engineering of diverse microbial strains, has led to more than 5 successfully launched products in collaboration with top tier industry partners. c-LEcta’s contribution to cost-efficient and sustainable production processes are of great importance to currently regulated industrial sectors like pharma and food.

The company has developed several proprietary methods for the identification of new enzymes from natural biodiversity, the optimization of enzymes for industrial processes, and the development of efficient enzyme production processes. c-LEcta's enzyme development platform has evolved over the past 10 years, following the primary objective of fast access to the optimal biocatalysts in a streamlined manner. The platform consists of unique and proprietary methods like cluster screening, c-LEcta mutagenesis and bioinformatics tools. Methods are regarded as both reliable and high in quality, thus resulting in excellent hit rates in enzyme libraries and speed of enzyme development projects. The success of c-LEcta’s enzyme engineering platform has been demonstrated over the last 10 years for various enzyme classes and engineering objectives.

c-LEcta's key contributions to the ShikiFactory100 project include: development of a structural bioinformatics platform for gene selection and enzyme engineering, and the implementation of low/medium throughput enzyme engineering methods. They are important contributors to Work Package 4: Gene Discovery and Protein Engineering.

The Principal Investigator for c-LEcta in the ShikiFactory100 project is Dr Andreas Vogel.

Find out more about c-LEcta here.



<< back
Partners

SilicoLife
SilicoLife

Braga, Portugal

SilicoLife
SilicoLife designs optimised microorganisms and novel pathways for industrial biotech applications.
EPFL
EPFL

Vaud, Switzerland

EPFL
EPFL was founded in 1969 and has established itself amongst the world’s best research and teaching institutions.
DTU
DTU

Copenhagen, Denmark

DTU
Technical University of Denmark (DTU) is recognised internationally in the areas of technology and natural sciences.
EMBL
EMBL

Heidelberg, Germany

EMBL
EMBL is Europe’s flagship laboratory for life sciences.
DSM
DSM

Delft, Netherlands

DSM
DSM is a global science-based company active in health, nutrition and materials.
University of Manchester
University of Manchester

Manchester, United Kingdom

University of Manchester
The University of Manchester is the largest single-site university in the UK, with research strengths across all scientific disciplines.
University of Minho
UMinho

Braga, Portugal

University of Minho
The University of Minho has expertise in the development of algorithms and computational tools for metabolic engineering.
Universidade NOVA de Lisboa
NOVA

Lisbon, Portugal

Universidade NOVA de Lisboa
Universidade NOVA de Lisboa is the youngest of Lisbon's state universities.
c-LEcta
c-LEcta

Leipzig, Germany

c-LEcta
c-LEcta specializes on the discovery, optimization and production of enzymes and engineered strains for the production of proteins and small molecules.
GalChimia
GalChimia

La Coruña, Spain

GalChimia
GalChimia is a service provider focused in the field of synthetic organic chemistry.
NNFCC
NNFCC

York, United Kingdom

NNFCC
NNFCC has over 17 years of experience in supporting the development of bio-based chemicals and products.
Want to get the latest Updates?